|
| 35050303 | Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts. | JAMA Oncol | 2022 |
| 35462055 | Radiation Therapy for Prostate Cancer Using HYpofractionation Directed by UltraSound (RAPHYDUS): A Brazilian Public Health Care System Study. | Pract Radiat Oncol | 2022 |
| 35513996 | RapidPlan hippocampal sparing whole brain model version 2-how far can we reduce the dose? | Med Dosim | 2022 |
| 33602654 | Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging. | Eur Urol Oncol | 2022 |
| 31411981 | Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer. | Eur Urol Oncol | 2021 |
| 33493615 | Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients. | Int J Radiat Oncol Biol Phys | 2021 |
| 34902034 | Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer. | JAMA Netw Open | 2021 |
| 34127013 | A novel external beam radiotherapy method for cervical cancer patients using virtual straight or bending boost areas; an in-silico feasibility study. | Radiat Oncol | 2021 |
| 33985797 | Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer. | Eur Urol | 2021 |
| 34196715 | Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features. | JAMA Netw Open | 2021 |
| 33035622 | Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control. | Radiother Oncol | 2021 |
| 32647353 | The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells. | Prostate Cancer Prostatic Dis | 2021 |
| 30992160 | Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. | Eur Urol | 2020 |
| 32000832 | Treatment planning comparison of volumetric modulated arc therapy employing a dual-layer stacked multi-leaf collimator and helical tomotherapy for cervix uteri. | Radiat Oncol | 2020 |
| 31718822 | Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials. | Eur Urol | 2020 |
| 32663537 | Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients. | Radiother Oncol | 2020 |
| 32562839 | Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2020 |
| 32169590 | A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer. | Pract Radiat Oncol | 2020 |
| 32373529 | Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer. | Front Oncol | 2020 |
| 32509582 | Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy. | Front Oncol | 2020 |
| 30326032 | Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis. | JAMA Oncol | 2019 |
| 31673667 | Association between Long-Term Second Malignancy Risk and Radiation: A Comprehensive Analysis of the Entire Surveillance, Epidemiology, and End Results Database (1973-2014). | Adv Radiat Oncol | 2019 |
| 32529134 | Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer. | Adv Radiat Oncol | 2019 |
| 31276777 | Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2019 |
| 31128144 | Enhancing Career Paths for Tomorrow's Radiation Oncologists. | Int J Radiat Oncol Biol Phys | 2019 |
| 30735235 | Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer. | JAMA Netw Open | 2019 |
| 31108142 | Testosterone Levels and Sexual Quality of Life After Stereotactic Body Radiation Therapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials. | Int J Radiat Oncol Biol Phys | 2019 |
| 30721720 | Ten-Year Outcomes of Moderately Hypofractionated (70Â Gy in 28 fractions) Intensity Modulated Radiation Therapy for Localized Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2019 |
| 27322703 | A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy. | Am J Clin Oncol | 2018 |
| 30050792 | Image-guided radiotherapy for prostate cancer. | Transl Androl Urol | 2018 |
| 30102201 | Content Validity of Anatomic Site-Specific Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item Sets for Assessment of Acute Symptomatic Toxicities in Radiation Oncology. | Int J Radiat Oncol Biol Phys | 2018 |
| 30143886 | Cost-effectiveness of Linac-based single-isocenter non-coplanar technique (HyperArcTM) for brain metastases radiosurgery. | Clin Exp Metastasis | 2018 |
| 29976500 | Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. | Int J Radiat Oncol Biol Phys | 2018 |
| 30652556 | Development of a Radiation Oncology-Specific Prospective Data Registry for Research and Quality Improvement: A Clinical Workflow-Based Solution. | JCO Clin Cancer Inform | 2018 |
| 29509865 | Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. | JAMA | 2018 |
| 28537990 | Impact of the Primary Information Source Used for Decision Making on Treatment Perceptions and Regret in Prostate Cancer. | Am J Clin Oncol | 2018 |
| 26535994 | Whole Versus Partial Bladder Radiation: Use of an Image-guided Hypofractionated IMRT Bladder-preservation Protocol. | Am J Clin Oncol | 2018 |
| 27558385 | Analytical modeling and feasibility study of a multi-GPU cloud-based server (MGCS) framework for non-voxel-based dose calculations. | Int J Comput Assist Radiol Surg | 2017 |
| 30657383 | Use of the Electronic Medical Record to Facilitate Intervention for Patients With Rising Prostate-Specific Antigen Values After Radical Prostatectomy: A Feasibility Study. | JCO Clin Cancer Inform | 2017 |
| 28437208 | Considerations for Quality Improvement in Radiation Oncology Therapy for Patients with Uncomplicated Painful Bone Metastases. | J Palliat Med | 2017 |
| 28111115 | Reply to Thomas Van den Broeck, R. Jeffrey Karnes, and Steven Joniau's Letter to the Editor re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766-73. | Eur Urol | 2017 |
| 28434660 | Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study. | Lancet Oncol | 2017 |
| 28187996 | Pattern of solid and hematopoietic second malignancy after local therapy for prostate cancer. | Radiother Oncol | 2017 |
| 28126301 | Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2017 |
| 28923575 | Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation. | Radiother Oncol | 2017 |
| 28759373 | Prospective radiotherapy for patients with oropharyngeal carcinoma - Authors' reply. | Lancet Oncol | 2017 |
| 27908620 | Location Matters: Stage I Non-Small-cell Carcinomas of the Lower Lobes Treated With Stereotactic Body Radiation Therapy Are Associated With Poor Outcomes. | Clin Lung Cancer | 2017 |
| 27997685 | Urinary toxicity after stereotactic body radiotherapy: The boy who cried wolf? | Cancer | 2017 |
| 27452951 | Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. | Eur Urol | 2017 |
| 25684394 | Does the addition of targeted prostate biopsies to standard systemic biopsies influence treatment management for radiation oncologists? | BJU Int | 2016 |